NCT00408369View on ClinicalTrials.gov

Prophylactic Antimalarial Activity of DB289 in Volunteers

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Prophylactic Activity Against Malaria
Interventions
DRUG

DB289

Trial Locations (1)

21205-2186

Johns Hopkins University School of Medicine, Baltimore

Sponsors
All Listed Sponsors
lead

Immtech Pharmaceuticals, Inc

INDUSTRY